Table 2

Hospital Resource Utilization and Patient Outcomes Associated with Respiratory Viral Testing in Hospitalized Patients

Sunita Mulpuru

, Shawn D. Aaron, Paul E. Ronksley, Nadine Lawrence, and Alan J. Forster

Author affiliations: Ottawa Hospital Research Institute, Ottawa (S. Mulpuru, S.D. Aaron, N. Lawrence, A.J. Forster); University of Ottawa, Ottawa, Ontario, Canada (S. Mulpuru, S.D. Aaron, A.J. Forster); The Ottawa Hospital, Ottawa (S. Mulpuru, S.D. Aaron, A.J. Forster); University of Calgary, Calgary, Alberta, Canada (P.E. Ronksley)

Main Article

Outcomes for hospitalized adults seeking treatment with respiratory symptoms, Ottawa, Ontario, Canada, 2004–2012*

Outcome variable	Study cohort, n = 24,567	With negative swab sample, n = 2,302	With positive swab sample, n = 420	p value†
Death, no. (%)	2,550 (10.4)	239 (10.4)	40 (9.5)	0.594
ICU admission, no. (%)	2,007 (8.2)	341 (14.8)	76 (18.1)	0.086
Days in ICU, mean ± SD	8.37 ± 10.64	11.22 ± 12.77	11.70 ± 14.03	0.771
Hospital isolation used, no. (%)	7,487 (30.5)	1,993 (86.6)	396 (94.3)	<0.001
No. days in isolation, mean ± SD	1.79 ± 6.79	4.73 ± 7.65	5.16 ± 5.39	0.27

*ICU, intensive care unit.
†For negative and positive swab samples.

Main Article

Page created: July 14, 2015

Page updated: July 14, 2015

Page reviewed: July 14, 2015

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.